A Cancer Breakthrough
"In a potential breakthrough in cancer research, scientists at the University of Pennsylvania have genetically engineered patients’ T cells — a type of white blood cell — to attack cancer cells in advanced cases of a common type of leukemia"
"Two of the three patients who received doses of the designer T cells in a clinical trial have remained cancer-free for more than a year, the researchers said."
